(Q40587632)
Statements
Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukemia (English)
Laurence Legros
Christine Bourcier
François-Xavier Mahon
Jill-Patrice Cassuto
Gilles Pagès
19 February 2004